Autolus’ Trials Will Assess AUTO3 as Potential Therapy in Leukemia, Lymphoma Patients
News
Autolus has initiated two Phase 1/2 trials to test AUTO3, a new CAR T-cell therapy that targets two cancer proteins instead of one. The trials, AMELIA and ALEXANDER, will be ... Read more